Additional Resources
1) Evidence-Based Tuberculosis Diagnosis
http://tbevidence.org/
2) National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5406a1.htm#top
3) APHL TB Self-Assessment Tool
http://www.aphl.org/aphlprograms/infectious/tuberculosis/Pages/tbtool.aspx
4) The Future of TB Laboratory Services
http://www.aphl.org/aphlprograms/infectious/tuberculosis/Documents/TB_Task_Force_Future
_2004.pdf
5) Mastering the Basics of TB Control- Development of a handbook on TB diagnostic methods
(European Centre for Disease Prevention and Control)
http://www.ecdc.europa.eu/en/publications/Publications/1105_TER_Basics_TB_control.pdf
6) CLSI M24-A2
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved
Standard—Second Addition
http://www.clsi.org/ (For purchase)
7) CLSI M48A
Laboratory Detection and Identification of Mycobacteria; Approved Guideline
http://www.clsi.org/ (For purchase)
8) Cumitechs from ASM Press
Cumitech 3B: Quality Systems in the Clinical Microbiology Laboratory
http://estore.asm.org/viewItemDetails.asp?ItemID=448
Cumitech 16A: Laboratory Diagnosis of the Mycobacterioses
http://estore.asm.org/viewItemDetails.asp?ItemID=397
Cumitech 31A: Verification and Validation of Procedures in the Clinical Microbiology Laboratory
http://estore.asm.org/viewItemDetails.asp?ItemID=858
1
Cumitech 39: Competency Assessment in the Clinical Microbiology Laboratory
http://estore.asm.org/viewItemDetails.asp?ItemID=387
Cumitech 40: Packing and Shipping of Diagnostic Specimens and Infectious Substance
http://estore.asm.org/viewItemDetails.asp?ItemID=391
Cumitech 41: Detection and Prevention of Clinical Microbiology Laboratory-Associated Errors
http://estore.asm.org/viewItemDetails.asp?ItemID=389
9) Tuberculosis Laboratory Aggregate Reports
http://www.cdc.gov/tb/publications/reportsarticles/labreports.htm
10) Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
http://www.cdc.gov/biosafety/publications/bmbl5/index.htm
11) Guidelines for Safe Work Practices in Human and Animal Medical Diagnostic Laboratories
Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel
http://www.cdc.gov/mmwr/pdf/other/su6101.pdf
12) ASM’s Revised Packing and Shipping Guidelines http://www.asm.org/images/pdf/Clinical/packship-7-15-2011.pdf
13) http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf
14) http://www.cdc.gov/tb/education/corecurr/index.htm
15) CDC. Reported Tuberculosis in the United States, 2010. Atlanta, GA: U.S. Department of Health
and Human Services, CDC, October 2011.
16) WHO; Multidrug and extensively drug-resistant TB: 2010 Global Report on Surveillance and
Response
17) Kent and Kubica, Public Health Mycobacteriology, A Guide for the Level III Laboratory, US Public
Health Service. 1985
18) ASM Press, Manual of Clinical Microbiology, 10th edition. Volume 1. James Versalovic, editor.
2011
19) Centers for Disease Control and Prevention. Guidelines for Preventing the Transmission of
Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR 2005;54(No. RR-17).
20) Use of Fluorochrome Staining for Detecting Acid-fast Mycobacteria, CDC
2
21) Monitoring the performance of mycobacteriology laboratories: a proposal for standardized
indicators; McCarthy, K.D et al.; The International Journal of Tuberculosis and Lung Disease,
Volume 12, Number 9, September 2008 , pp. 1015-1020
22) D. Rickwood, T. Ford, and J. Steensgaard. Centrifugation, Essential Data. John Wiley & Sons.
Published in association with BIOS Scientific Publishers Limited, 1994.
23) Rickman TW, Moyer NP. Increased Sensitivity of Acid-Fast Smears. Journal of Clinical
Microbiology. 1980; 11:618-20.
24) A Centrifuge Primer. Published by Spinco Division of Beckman Instruments, Inc., Palo Alto,
California. Copyright 1980, Beckman Instruments, Inc.
25) Miller, M.J., R. Astles, T. Baszler, K. Chapin, R. Carey, L. Garcia, L. Gray, D. Larone, M. Pentella, A.
Pollock, D.S. Shapiro, E. Weirich, and D. Wiedbrauk. Guidelines for safe work practices in Human
and Animal medical diagnostic laboratories. MMWR, Supplement, January 6, 2012.
http://www.cdc.gov/mmwr/pdf/other/su6101.pdf
26) Delany,J., J. Rodriguez, D. Holmes, M. Pentella, K. Baxley, and K. Shah. CDC/APHL Laboratory
Biosafety Competencies for the BSL-2, BSL-3, and BSL-4 Laboratories. MMWR, Supplement,
April 15, 2011. http://www.cdc.gov/mmwr/pdf/other/su6002.pdf
27) Treatment of Tuberculosis. Centers for Disease Control and Prevention, American Thoracic
Society, CDC, and Infectious Diseases Society of America. MMWR 2003; 52 (No. RR-11)
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
28) An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous
Mycobacterial Diseases. American Thoracic Society Documents
http://ajrccm.atsjournals.org/content/175/4/367.full
29) Plan to Combat Extensively Drug-Resistant Tuberculosis. Recommendations of the Federal
Tuberculosis Task Force. Morbidity and Mortality Weekly Report. Recommendations and
Reports February 13, 2009 / Vol. 58 / No. RR-3
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5803a1.htm?s_cid=rr5803a1_e
3